AIM Specialty Health® (AIM) Acquires Applied Pathways to Accelerate Delivery of Technology-Enabled, Evidence-Based Clinical Solutions for Payers and Providers
Aug 17, 2017
Chicago, IL, August 17, 2017 – AIM Specialty Health, a leading specialty benefits management company, has acquired Applied Pathways, a leader in visual authoring and rules engine software for health care. AIM currently leverages Applied Pathways’ software solutions to simplify, encode and utilize complex clinical content into a standardized, repeatable, evidence-based system for making decisions within AIM clinical programs.
“Our companies share a common goal to promote evidence-based medicine and ensure that services are appropriate, safe and affordable,”
Together the companies have deep experience in both the payer and provider markets. For more than two decades, AIM has been a leader in solutions for clinical review, provider collaboration and member engagement. In addition to its work with AIM, Applied Pathways’ clients have used its sophisticated visual authoring and rules engine platform to inject clinical knowledge into their applications, such as electronic health records, patient portals, nurse triage call centers, and other clinical applications.
Combined, the companies offer an industry-leading approach to both clinical decision support and clinical appropriateness review, supporting providers and health plans. Their technology-enabled and evidence-based solutions mean better clinical decision support tools that increase the quality, efficiency and value of health care decisions for patients, physicians, and payers.
In addition, both AIM and Applied Pathways are qualified participants in the CMS Appropriate Use Criteria Program addressing outpatient advanced imaging services. The program, part of the Protecting Access to Medicare Act, mandates that providers use CMS-approved clinical decision support criteria, through a qualified mechanism, that documents the appropriateness of high-tech, diagnostic imaging in order to receive full reimbursement for Medicare fee-for-service beneficiaries effective January 1, 2019.
“Our companies share a common goal to promote evidence-based medicine and ensure that services are appropriate, safe and affordable,” said Brandon Cady, president and CEO of AIM. “Together, AIM and Applied Pathways support greater provider collaboration with highly automated tools that enhance clinical value for physicians and health plans. This marks another important investment in innovation for our customers.”
Steve Lefar, CEO of Applied Pathways, said, “We are clearly aligned in our mutual vision to make it easier for physicians and other care givers to measurably reduce variance and improve quality of care. Joining forces with AIM gives us new opportunities to drive even more meaningful solutions that deliver real, measurable value to our expanding set of customers.”
AIM Specialty Health
Lori McLaughlin: 317.407.7403
# # #
AIM Specialty Health® provides clinical solutions that drive appropriate, safe and affordable care. Serving more than 50 million members across 50 states, D.C. and US territories, AIM promotes optimal care through use of evidence-based clinical guidelines and real-time decision support for both providers and their patients. The AIM platform delivers significant cost-of-care savings across an expanding set of clinical domains including radiology, cardiology, oncology, specialty drugs, sleep medicine, musculoskeletal and genetic testing. AIM is a wholly-owned subsidiary of Anthem, Inc. (ANTM). For more information, visit www.aimspecialtyhealth.com and www.aiminform.com.
About Applied Pathways
Applied Pathways is focused on reducing the unwanted variance in healthcare that leads to unnecessary spending without positively impacting quality of care. Our visual authoring, rules engine software, and workflow specific EHR embeddable applications simplify the process of encoding and utilizing clinical knowledge and institutional best practices to deliver a standardized, repeatable system for making decisions across the clinical continuum. To learn more visit appliedpathways.com or follow us on Twitter at @appliedpathways.